Treos Bio

Treos Bio Overview

  • Founded
  • 2013
  • Status
  • Private
  • Employees
  • 6
  • Latest Deal Type
  • Early Stage VC
  • Latest Deal Amount
  • $8M
Latest Deal Amount
  • Investors
  • 2

Treos Bio General Information


Developer of immunotherapy vaccines intended for cancer cell destruction. The company's vaccines are designed to exclude autoimmunity and induce tumor-specific immune responses to be safer and more effective in patients who cannot benefit from current immunotherapies, enabling cancer patients to treat cancer through vaccines and diagnostic tests.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Diagnostic Equipment
Outcome Management (Healthcare)
Primary Office
  • The Harley Building
  • 79 New Cavendish Street
  • London W1W 6XB
  • England, United Kingdom
+44 020 0000 0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Treos Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC 13-Feb-2017 $8M 000 Completed Generating Revenue
1. Early Stage VC (Series A) 01-Jan-2014 Completed Generating Revenue

Treos Bio Competitors (11)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing
ImmunityBio Angel-Backed Culver City, CA 00000 000000000000 00000
0000 00000000000 Venture Capital-Backed Cambridge, MA 00 00000 0000000000 0 00000
000000000 00000000 Venture Capital-Backed Rockville, MD 000.00 0000000000 0 000.00
000000000 Venture Capital-Backed Gaithersburg, MD 00 000.00 00000000000 000.00
00000000 Private Equity-Backed McLean, VA 00 000.00 000000000. 0 000.00

Treos Bio Executive Team (6)

Name Title Board Seat Contact Info
John Hautman JD Co-Founder, Chief Legal Officer & Chief Executive Officer
Gabor Illés Chief Financial Officer & Board Member
Enikő Tőke Ph.D Chief Scientific Officer & Board Member
Franco Lori Ph.D Chief Medical Officer

2 Former Executives

Treos Bio Board Members (7)

To view Treos Bio‘s full board member team, request access »
Name Representing Role Since
Christopher Gallen MD Self Chairman 000 0000
Daniel Hallgarten Self Board Member 000 0000
Enikő Tőke Ph.D Treos Bio Chief Scientific Officer & Board Member 000 0000
Gabor Illés Treos Bio Chief Financial Officer & Board Member 000 0000
Peter Kadas Treos Bio Board Member 000 0000

2 Former Board Members

Treos Bio Investors (2)

To view Treos Bio‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
BXR Group PE/Buyout Minority 000 0000 000000 0
Conor Fund Seed Capital Venture Capital Minority 000 0000 000000 0

Ready to get started?

Request a free trial